Importantly, nanoparticles can be engineered to co‐deliver ferroptosis inducers alongside ncRNA modulators, thus directly targeting the AR ferroptosis crosstalk implicated in PCa progression and therapy resistance. Here, AR is linked to posterior cortical atrophy.